Healthcare provider profile · identity verified

Mary E Clawson, M.D.

Internal Medicine · BAY SPRINGS, MS · NPI 1194825513

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	230	67
Potassium Chloride	Potassium Chloride	229	45
Gabapentin	Gabapentin	180	47
Furosemide	Furosemide	179	39
Pantoprazole Sodium	Pantoprazole Sodium	173	51
Levothyroxine Sodium	Levothyroxine Sodium	149	39
Omeprazole	Omeprazole	135	35
Trazodone Hcl	Trazodone Hcl	116	27
Quetiapine Fumarate	Quetiapine Fumarate	115	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	107	22
Atorvastatin Calcium	Atorvastatin Calcium	99	36
Donepezil Hcl	Donepezil Hcl	97	18
Losartan Potassium	Losartan Potassium	97	25
Memantine Hcl	Memantine Hcl	93	18
Duloxetine Hcl	Duloxetine Hcl	91	23
Carvedilol	Carvedilol	85	23
Mirtazapine	Mirtazapine	83	12
Famotidine	Famotidine	79	19
Metformin Hcl	Metformin Hcl	73	27
Diclofenac Sodium	Diclofenac Sodium	71	31
Hydrochlorothiazide	Hydrochlorothiazide	70	27
Buspirone Hcl	Buspirone Hcl	67	11
Eliquis	Apixaban	66	18
Lisinopril	Lisinopril	64	24
Metoprolol Succinate	Metoprolol Succinate	62	24
Baclofen	Baclofen	57	18
Metoprolol Tartrate	Metoprolol Tartrate	56	14
Rosuvastatin Calcium	Rosuvastatin Calcium	50	11
Ropinirole Hcl	Ropinirole Hcl	49	12
Clopidogrel	Clopidogrel Bisulfate	47	17
Escitalopram Oxalate	Escitalopram Oxalate	47	14
Levetiracetam	Levetiracetam	46	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	43	15
Fentanyl	Fentanyl	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	37	21
Tramadol Hcl	Tramadol Hcl	36	11
Glimepiride	Glimepiride	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	suppressed
Lactulose	Lactulose	35	12
Sertraline Hcl	Sertraline Hcl	35	suppressed
Atenolol	Atenolol	34	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	12
Albuterol Sulfate Hfa	Albuterol Sulfate	33	12
Fluticasone Propionate	Fluticasone Propionate	33	19
Meloxicam	Meloxicam	32	18
Allopurinol	Allopurinol	31	13
Spironolactone	Spironolactone	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	19
Gemfibrozil	Gemfibrozil	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	14
Sucralfate	Sucralfate	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Jantoven	Warfarin Sodium	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	12
Latanoprost	Latanoprost	22	suppressed
Rivastigmine	Rivastigmine	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Lumigan	Bimatoprost	21	suppressed
Novolin R	Insulin Regular, Human	21	suppressed
Simvastatin	Simvastatin	21	suppressed
Ondansetron Hcl	Ondansetron Hcl/Pf	20	11
Ibu	Ibuprofen	19	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	19	suppressed
Glipizide	Glipizide	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	12
Mounjaro	Tirzepatide	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Mupirocin	Mupirocin	16	11
Nifedipine Er	Nifedipine	16	suppressed
Prednisone	Prednisone	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valsartan	Valsartan	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Cefdinir	Cefdinir	12	12
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Finasteride	Finasteride	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Ozempic	Semaglutide	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Torsemide	Torsemide	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error